Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gender differences in platelet GPIIb-IIIa activation

N Faraday1, P J Goldschmidt-Clermont, P F Bray

  • 1Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Thrombosis and Haemostasis
|April 1, 1997
PubMed
Summary

Women exhibit enhanced platelet activation compared to men, with greater GPIIb-IIIa receptor availability. This suggests hormonal influences on platelet function and thrombotic disease risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

3D ELECTRICAL IMPEDANCE TOMOGRAPHY RECONSTRUCTIONS FROM SIMULATED ELECTRODE DATA USING DIRECT INVERSION t<sup>exp</sup> AND CALDERÓN METHODS.

Inverse problems and imaging (Springfield, Mo.)·2022
Same author

The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y<sub>12</sub> inhibition.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Utility of blood pressure genetic risk score in admixed Hispanic samples.

Journal of human hypertension·2016
Same author

Protease receptor antagonism to target blood platelet therapies.

Clinical pharmacology and therapeutics·2015
Same author

MicroRNAs in platelet production and activation.

Journal of thrombosis and haemostasis : JTH·2013
Same author

The minor allele of GP6 T13254C is associated with decreased platelet activation and a reduced risk of recurrent cardiovascular events and mortality: results from the SMILE-Platelets project.

Journal of thrombosis and haemostasis : JTH·2010

Area of Science:

  • Cardiovascular Biology
  • Hematology
  • Platelet Physiology

Background:

  • Gender disparities exist in thrombotic disease development.
  • Platelet reactivity is a key factor in vascular thrombosis.
  • Platelet GPIIb-IIIa receptor activation is central to thrombus formation.

Purpose of the Study:

  • To investigate gender differences in platelet GPIIb-IIIa receptor function.
  • To quantify sex-based variations in fibrinogen and PAC-1 binding to GPIIb-IIIa.
  • To explore potential hormonal modulation of GPIIb-IIIa activation.

Main Methods:

  • Flow cytometry was used to measure FITC-labeled fibrinogen and PAC-1 antibody binding to platelets.
  • Platelets were activated with ADP or thrombin receptor activating peptide (TRAP).

Related Experiment Videos

  • Quantitative Western blotting and monoclonal antibody binding assays assessed total GPIIb-IIIa expression.

    • Main Results:

    • No significant gender difference in total GPIIb-IIIa receptor expression was observed.
    • Platelets from women showed significantly higher fibrinogen and PAC-1 binding post-activation compared to men.
    • GPIIb-IIIa receptor "activatability" was greater in premenopausal women, potentially linked to menstrual cycle phase.

    Conclusions:

    • Premenopausal women's platelets have more "activatable" GPIIb-IIIa receptors than men's.
    • Estrogen and/or progestin levels may modulate GPIIb-IIIa receptor function.
    • These findings may contribute to understanding gender-specific thrombotic disease risks.